| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |